| 12/1/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 11/24/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 11/17/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 11/11/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 11/5/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 10/30/2025 | Morgan Stanley | Lower Target | Overweight ➝ Overweight | $397.00 ➝ $373.00 | |
| 10/30/2025 | Keefe, Bruyette & Woods | Lower Target | Outperform ➝ Outperform | $358.00 ➝ $345.00 | |
| 10/28/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 10/22/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 10/14/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 10/13/2025 | Keefe, Bruyette & Woods | Lower Target | Outperform ➝ Moderate Buy | $370.00 ➝ $358.00 | |
| 10/9/2025 | Deutsche Bank Aktiengesellschaft | Initiated Coverage | Buy | $400.00 | |
| 10/9/2025 | Zacks Research | Downgrade | Strong-Buy ➝ Hold | | |
| 10/8/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 10/3/2025 | BMO Capital Markets | Initiated Coverage | Market Perform | $358.00 | |
| 9/27/2025 | Weiss Ratings | Reiterated Rating | Hold (C) ➝ Hold (C) | | |
| 9/8/2025 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $315.00 ➝ $397.00 | |
| 7/31/2025 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $312.00 ➝ $315.00 | |
| 7/31/2025 | Keefe, Bruyette & Woods | Reiterated Rating | Outperform ➝ Outperform | $365.00 ➝ $370.00 | |
| 7/14/2025 | Citigroup | Downgrade | Market Perform | | |
| 7/14/2025 | JMP Securities | Reiterated Rating | Market Outperform ➝ Market Perform | $230.00 | |
| 7/14/2025 | Citizens Jmp | Downgrade | Outperform ➝ Market Perform | | |
| 7/14/2025 | Keefe, Bruyette & Woods | Boost Target | Outperform ➝ Outperform | $257.00 ➝ $365.00 | |
| 7/11/2025 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $194.00 ➝ $282.00 | |
| 7/10/2025 | Wolfe Research | Reiterated Rating | Outperform ➝ Outperform | | |
| 7/7/2025 | The Goldman Sachs Group | Boost Target | Buy ➝ Buy | $266.00 ➝ $298.00 | |
| 6/23/2025 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $175.00 ➝ $312.00 | |
| 5/15/2025 | The Goldman Sachs Group | Boost Target | Buy ➝ Buy | $234.00 ➝ $266.00 | |
| 5/12/2025 | Keefe, Bruyette & Woods | Boost Target | Outperform ➝ Outperform | $238.00 ➝ $257.00 | |
| 5/1/2025 | Morgan Stanley | Boost Target | Equal Weight ➝ Equal Weight | $173.00 ➝ $175.00 | |
| 5/1/2025 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $180.00 ➝ $194.00 | |
| 4/8/2025 | Wells Fargo & Company | Lower Target | Equal Weight ➝ Equal Weight | $199.00 ➝ $180.00 | |
| 4/8/2025 | JMP Securities | Upgrade | Market Perform ➝ Market Outperform | $230.00 ➝ $230.00 | |
| 4/8/2025 | Citizens Jmp | Upgrade | Market Perform ➝ Outperform | $230.00 | |
| 4/7/2025 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $306.00 ➝ $173.00 | |
| 4/2/2025 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $281.00 ➝ $252.00 | |
| 3/14/2025 | The Goldman Sachs Group | Lower Target | Buy ➝ Buy | $321.00 ➝ $281.00 | |
| 3/13/2025 | Morgan Stanley | Lower Target | Overweight ➝ Overweight | $400.00 ➝ $306.00 | |
| 2/6/2025 | Keefe, Bruyette & Woods | Reiterated Rating | Outperform ➝ Outperform | $319.00 ➝ $339.00 | |
| 1/14/2025 | Wells Fargo & Company | Lower Target | Equal Weight ➝ Equal Weight | $318.00 ➝ $305.00 | |
| 1/13/2025 | Keefe, Bruyette & Woods | Lower Target | Outperform ➝ Outperform | $339.00 ➝ $319.00 | |
| 12/20/2024 | Keefe, Bruyette & Woods | Upgrade | Market Perform ➝ Outperform | $269.00 ➝ $339.00 | |
| 12/12/2024 | Wells Fargo & Company | Boost Target | Equal Weight ➝ Equal Weight | $266.00 ➝ $318.00 | |
| 10/9/2024 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $306.00 ➝ $308.00 | |
| 10/8/2024 | UBS Group | Boost Target | Neutral ➝ Neutral | $255.00 ➝ $265.00 | |
| 9/23/2024 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $273.00 ➝ $306.00 | |
| 9/12/2024 | Wells Fargo & Company | Initiated Coverage | Equal Weight | $258.00 | |
| 9/11/2024 | The Goldman Sachs Group | Upgrade | Neutral ➝ Buy | $246.00 ➝ $276.00 | |
| 7/25/2024 | Keefe, Bruyette & Woods | Boost Target | Market Perform ➝ Market Perform | $219.00 ➝ $245.00 | |
| 7/25/2024 | The Goldman Sachs Group | Boost Target | Neutral ➝ Neutral | $223.00 ➝ $251.00 | |
| 7/23/2024 | Morgan Stanley | Boost Target | Overweight ➝ Overweight | $231.00 ➝ $276.00 | |
| 7/12/2024 | Keefe, Bruyette & Woods | Boost Target | Market Perform ➝ Market Perform | $193.00 ➝ $219.00 | |
| 7/9/2024 | UBS Group | Boost Target | Neutral ➝ Neutral | $195.00 ➝ $220.00 | |
| 6/21/2024 | Morgan Stanley | Reiterated Rating | Overweight ➝ Overweight | $220.00 ➝ $220.00 | |
| 4/9/2024 | JMP Securities | Reiterated Rating | Market Perform | | |
| 2/5/2024 | UBS Group | Boost Target | Neutral ➝ Neutral | $176.00 ➝ $180.00 | |
| 1/29/2024 | Keefe, Bruyette & Woods | Reiterated Rating | Market Perform | $193.00 | |
| 1/9/2024 | UBS Group | Downgrade | Buy ➝ Neutral | $160.00 ➝ $176.00 | |
| 12/19/2023 | The Goldman Sachs Group | Boost Target | Neutral ➝ Neutral | $149.00 ➝ $169.00 | |
| 10/3/2023 | UBS Group | Boost Target | Buy ➝ Buy | $155.00 ➝ $160.00 | |
| 8/22/2023 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $158.00 ➝ $140.00 | |
| 4/12/2023 | Morgan Stanley | Upgrade | Equal Weight ➝ Overweight | $102.00 ➝ $131.00 | |
| 4/12/2023 | UBS Group | Upgrade | Sell ➝ Buy | | |
| 2/6/2023 | Morgan Stanley | Boost Target | Equal Weight | $94.00 ➝ $102.00 | |
| 2/2/2023 | Keefe, Bruyette & Woods | Boost Target | Outperform | $132.50 ➝ $137.00 | |
| 1/12/2023 | Morgan Stanley | Boost Target | Equal Weight | $87.00 ➝ $94.00 | |
| 1/11/2023 | The Goldman Sachs Group | Upgrade | Neutral ➝ Buy | $105.00 ➝ $125.00 | |
| 1/9/2023 | UBS Group | Boost Target | Sell | $90.00 ➝ $95.00 | |
| 10/27/2022 | The Goldman Sachs Group | Boost Target | Neutral | $90.00 ➝ $101.00 | |
| 10/27/2022 | Keefe, Bruyette & Woods | Downgrade | Outperform ➝ Market Perform | $106.00 ➝ $109.00 | |
| 9/23/2022 | UBS Group | Downgrade | Neutral ➝ Sell | $99.00 ➝ $85.00 | |
| 8/1/2022 | UBS Group | Lower Target | Neutral | $104.00 ➝ $99.00 | |
| 7/18/2022 | Morgan Stanley | Lower Target | Equal Weight | $136.00 ➝ $97.00 | |
| 7/13/2022 | The Goldman Sachs Group | Lower Target | Neutral | $111.00 ➝ $93.00 | |
| 7/8/2022 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $142.00 ➝ $118.00 | |
| 4/7/2022 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $161.00 ➝ $142.00 | |
| 3/9/2022 | Piper Sandler | Lower Target | Overweight ➝ Overweight | $180.00 ➝ $161.00 | |
| 3/8/2022 | Morgan Stanley | Lower Target | Equal Weight | $156.00 ➝ $136.00 | |
| 2/3/2022 | Piper Sandler | Lower Target | | $185.00 ➝ $180.00 | |
| 1/6/2022 | The Goldman Sachs Group | Downgrade | Buy ➝ Neutral | $176.00 ➝ $141.00 | |
| 1/4/2022 | UBS Group | Lower Target | Neutral | $155.00 ➝ $148.00 | |
| 12/8/2021 | Morgan Stanley | Downgrade | Overweight ➝ Equal Weight | $180.00 ➝ $156.00 | |
| 11/4/2021 | UBS Group | Downgrade | Buy ➝ Neutral | $148.00 ➝ $155.00 | |
| 10/11/2021 | Morgan Stanley | Boost Target | Overweight | $160.00 ➝ $168.00 | |
| 4/15/2021 | JMP Securities | Reiterated Rating | Outperform ➝ Market Perform | | |
| 4/13/2021 | Morgan Stanley | Boost Target | Overweight | $155.00 ➝ $160.00 | |
| 4/9/2021 | JMP Securities | Downgrade | Outperform ➝ Market Perform | | |
| 4/7/2021 | Morgan Stanley | Boost Target | Overweight | $155.00 ➝ $160.00 | |
| 4/1/2021 | UBS Group | Boost Target | Buy | $132.00 ➝ $145.00 | |
| 3/25/2021 | The Goldman Sachs Group | Upgrade | Buy ➝ Conviction-Buy | $139.00 ➝ $162.00 | |
| 3/19/2021 | The Goldman Sachs Group | Upgrade | Buy ➝ Conviction-Buy | $139.00 ➝ $162.00 | |
| 3/18/2021 | Morgan Stanley | Boost Target | Overweight | $144.00 ➝ $155.00 | |
| 3/16/2021 | Piper Sandler | Boost Target | | $140.00 ➝ $160.00 | |
| 3/12/2021 | Morgan Stanley | Boost Target | Overweight | $144.00 ➝ $155.00 | |
| 2/4/2021 | Morgan Stanley | Boost Target | Overweight | $135.00 ➝ $144.00 | |
| 2/3/2021 | JMP Securities | Boost Target | | $125.00 ➝ $133.00 | |
| 1/5/2021 | Wolfe Research | Upgrade | Peer Perform ➝ Outperform | $95.00 ➝ $134.00 | |
| 12/16/2020 | Evercore ISI | Initiated Coverage | Buy | $125.00 | |
| 12/14/2020 | Morgan Stanley | Boost Target | Overweight | $102.00 ➝ $135.00 | |